Company intelligence / Profile preview

First Rare Materials

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

First Rare is a biotechnology company focused on developing transformative therapies for rare genetic diseases with high unmet medical needs. The company's lead program is centered on treating cystinosis, a lysosomal storage disorder, by targeting the underlying transport mechanisms of cystine. By leveraging deep expertise in rare disease biology and medicinal chemistry, First Rare aims to improve the standard of care and quality of life for patients suffering from debilitating orphan conditions.

Therapeutic areas: Rare Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on First Rare Materials.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on First Rare Materials.

Explore the full profile